2017 Buyer’s Guide

This buyer’s guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

TRILUMINATE Trial Begins for Abbott Vascular's Transcatheter Tricuspid Valve Repair System

 

August 11, 2017—Abbott Vascular announced that the first patient has been enrolled in the TRILUMINATE clinical study to evaluate the company's clip-based transcatheter tricuspid valve repair (TTVR) system for treating patients with moderate or severe tricuspid regurgitation. The TTVR system builds on the company's MitraClip system, which has shown to predictably and effectively treat mitral regurgitation. TRILUMINATE is expected to support Abbott Vascular's application for CE Mark approval of the device in Europe.

The prospective, single-arm, multicenter study is designed to evaluate the performance of the TTVR clip-based technology in approximately 75 symptomatic patients at 25 sites in the United States and Europe. The primary endpoints are an echocardiographic tricuspid regurgitation reduction of ≥ 1 grade at 30 days after the procedure and the assessment of major adverse events at 6 months.

The first patient was enrolled by Paul Sorajja, MD, at Abbott Northwestern Hospital in Minneapolis, Minnesota. The study's Lead Investigator is Georg Nickenig, MD, Professor and Chief, Department of Cardiology, University Hospital, Bonn, Germany.

In the company's announcement, Prof. Nickenig commented, "Current pharmacological and surgical treatment options are not meeting the needs of people living with tricuspid regurgitation. Abbott's MitraClip has shown positive results for mitral regurgitation, and we hope this study shows that a similar clip-based technology may effectively treat people with tricuspid regurgitation."

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.